Abstract
Major depressive disorder is one of the leading causes of disability in the world, with an incidence rate of 16%, causing a heavy social and economic burden. Moreover, pain and depression often coexist, and the factors that need to be considered to understand this coexistence are more complex. A deeper understanding of the mechanisms behind the coexistence of pain and depression is likely to find a more effective way to treat depression in the context of pain. In this chapter, we outline the prevalence of pain and depression comorbidities and the shared neurobiological mechanisms between pain and depression. Additionally, we discuss animal models commonly used in the current study to simulate comorbidities of pain and depression. Finally, we also present some current therapies based on an understanding of the neurobiological changes that occur in pain and depression comorbidities, as well as ketamine as a promising approach in the treatment of pain and depression comorbidities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackerman LL, Follett KA, Rosenquist RW (2003) Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 26(1):668–677
Aguera-Ortiz L, Failde I, Mico JA et al (2011) Pain as a symptom of depression: prevalence and clinical correlates in patients attending psychiatric clinics. J Affect Disord 130(1-2):106–112
Alba-Delgado C, Llorca-Torralba M, Horrillo I et al (2013) Chronic pain leads to concomitant noradrenergic impairment and mood disorders. Biol Psychiatry 73(1):54–62
Albert PR, Vahid-Ansari F, Luckhart C (2014) Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression. Front Behav Neurosci 8:199
Almeida C, DeMaman A, Kusuda R et al (2015) Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain. Pain 156(3):504–513
Apkarian AV, Bushnell MC, Treede RD et al (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9(4):463–484
Arnold LM (2007) Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 8(Suppl 2):S63–S74
Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17(9):1113–1e88
Bair MJ, Robinson RL, Katon W et al (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163(20):2433–2445
Baliki MN, Mansour A, Baria AT et al (2013) Parceling human accumbens into putative core and shell dissociates encoding of values for reward and pain. J Neurosci 33(41):16383–16393
Barbanti P, Fofi L, Aurilia C et al (2013) Dopaminergic symptoms in migraine. Neurol Sci 34(Suppl 1):S67–S70
Bazzichi L, Giannaccini G, Betti L et al (2006) Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8(4):R99
Berman RM, Cappiello A, Anand A et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354
Bigman D, Kunaparaju S, Bobrin B (2017) Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. BMJ Case Rep 2017
Blandini F, Rinaldi L, Tassorelli C et al (2006) Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia 26(2):136–142
Brannan SK, Mallinckrodt CH, Brown EB et al (2005) Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 39(1):43–53
Bravo L, Torres-Sanchez S, Alba-Delgado C et al (2014) Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats. Eur Neuropsychopharmacol 24(6):996–1003
Bushnell MC, Ceko M, Low LA (2013) Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci 14(7):502–511
Carr EC, Nicky Thomas V, Wilson-Barnet J (2005) Patient experiences of anxiety, depression and acute pain after surgery: a longitudinal perspective. Int J Nurs Stud 42(5):521–530
Chandran A, Iyo AH, Jernigan CS et al (2013) Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog Neuropsychopharmacol Biol Psychiatry 40:240–245
Cocksedge KA, Simon C, Shankar R (2014) A difficult combination: chronic physical illness, depression, and pain. Br J Gen Pract 64(626):440–441
Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87(2):149–158
Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 61(Suppl 6):7–11
DeVeaugh-Geiss AM, West SL, Miller WC et al (2010) The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med 11(5):732–741
Diazgranados N, Ibrahim L, Brutsche NE et al (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67(8):793–802
Duric V, McCarson KE (2006a) Effects of analgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. J Pharmacol Exp Ther 319(3):1235–1243
Duric V, McCarson KE (2006b) Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain 7(8):544–555
Eisenberger NI, Lieberman MD, Williams KD (2003) Does rejection hurt? An FMRI study of social exclusion. Science 302(5643):290–292
Fukuhara K, Ishikawa K, Yasuda S et al (2012) Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell Mol Neurobiol 32(6):971–977
Gerrits MM, van Oppen P, van Marwijk HW, et al (2014) Pain and the onset of depressive and anxiety disorders. Pain 155(1): 53-59
Goffer Y, Xu D, Eberle SE et al (2013) Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci 33(48):19034–19044
Hache G, Guiard BP, Nguyen TH et al (2015) Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain. Eur J Pain 19(3):322–333
Hauser W, Wolfe F, Tolle T et al (2012) The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26(4):297–307
Hilderink PH, Burger H, Deeg DJ et al (2012) The temporal relation between pain and depression: results from the longitudinal aging study Amsterdam. Psychosom Med 74(9):945–951
Hocking G, Cousins MJ (2003) Ketamine in chronic pain management: an evidence-based review. Anesth Analg 97(6):1730–1739
Hooten WM (2016) Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment. Mayo Clin Proc 91(7):955–970
Karege F, Perret G, Bondolfi G et al (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109(2):143–148
Kerr BJ, Bradbury EJ, Bennett DL et al (1999) Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci 19(12):5138–5148
Kim H, Chen L, Lim G et al (2012) Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122(8):2940–2954
Leino P, Magni G (1993) Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees. Pain 53(1):89–94
Li JX (2015) Pain and depression comorbidity: a preclinical perspective. Behav Brain Res 276:92–98
Li N, Lee B, Liu RJ et al (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329(5994):959–964
Li Q, Yue N, Liu SB et al (2014) Effects of chronic electroacupuncture on depression- and anxiety-like behaviors in rats with chronic neuropathic pain. Evid Based Complement Alternat Med 2014:158987
Mann JJ, Malone KM (1997) Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 41(2):162–171
Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD et al (2008) Relationships among pain, anxiety, and depression in primary care. Depress Anxiety 25(7):593–600
Moriam S, Sobhani ME (2013) Epigenetic effect of chronic stress on dopamine signaling and depression. Genet Epigenet 5:11–16
Mutschler I, Ball T, Wankerl J et al (2012) Pain and emotion in the insular cortex: evidence for functional reorganization in major depression. Neurosci Lett 520(2):204–209
Ohayon MM (2004) Specific characteristics of the pain/depression association in the general population. J Clin Psychiatry 65(Suppl 12):5–9
Okubo M, Castro A, Guo W et al (2013) Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms. J Neurosci 33(12):5152–5161
Ordway GA (1997) Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 836:233–252
Pearson-Fuhrhop KM, Dunn EC, Mortero S et al (2014) Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS One 9(5):e93772
Piccinni A, Marazziti D, Catena M et al (2008) Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105(1-3):279–283
Price RB, Nock MK, Charney DS et al (2009) Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66(5):522–526
Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14(9):609–625
Sagheddu C, Aroni S, De Felice M et al (2015) Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology 97:383–393
Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62(1):63–77
Sekine A, Hozumi S, Shimizu T (2016) Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: a prospective cohort study. Psychiatry Res 242:240–244
Sellmeijer J, Mathis V, Hugel S et al (2018) Hyperactivity of anterior cingulate cortex areas 24a/24b drives chronic pain-induced anxiodepressive-like consequences. J Neurosci 38(12):3102–3115
Shi M, Wang JY, Luo F (2010) Depression shows divergent effects on evoked and spontaneous pain behaviors in rats. J Pain 11(3):219–229
Sigtermans MJ, van Hilten JJ, Bauer MC et al (2009) Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 145(3):304–311
Sobocki P, Jonsson B, Angst J et al (2006) Cost of depression in Europe. J Ment Health Policy Econ 9(2):87–98
Suzuki T, Amata M, Sakaue G et al (2007) Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth Analg 104(6):1570–1577. table of contents
Tateiwa H, Kawano T, Nishigaki A et al (2018) The role of hippocampal brain-derived neurotrophic factor in age-related differences in neuropathic pain behavior in rats. Life Sci 197:56–66
Tukey DS, Lee M, Xu D et al (2013) Differential effects of natural rewards and pain on vesicular glutamate transporter expression in the nucleus accumbens. Mol Brain 6:32
Ushida T, Tani T, Kanbara T et al (2002) Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med 27(5):524–528
Verne GN, Price DD, Callam CS et al (2012) Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors. J Pain 13(9):901–909
Von Korff M, Dworkin SF, Le Resche L et al (1988) An epidemiologic comparison of pain complaints. Pain 32(2):173–183
Wang J, Goffer Y, Xu D et al (2011) A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 115(4):812–821
Weber G, Yao J, Binns S et al (2018) Case report of subanesthetic intravenous ketamine infusion for the treatment of neuropathic pain and depression with suicidal features in a pediatric patient. Case Rep Anesthesiol 2018:9375910
Wohlreich MM, Sullivan MD, Mallinckrodt CH et al (2009) Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis. Psychosomatics 50(4):402–412
Zhang GF, Wang J, Han JF et al (2016) Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model. Neurosci Lett 631:7–12
Zhao J, Seereeram A, Nassar MA et al (2006) Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 31(3):539–548
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Tang, XH., Yang, JJ. (2020). Effects of Ketamine on Pain and Depression Comorbidity. In: Hashimoto, K., Ide, S., Ikeda, K. (eds) Ketamine. Springer, Singapore. https://doi.org/10.1007/978-981-15-2902-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-15-2902-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2901-6
Online ISBN: 978-981-15-2902-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)